Back

SCORED and SOLOIST: the next scores for SGLT2 inhibitors

Cardiovascular Research

13 January 2021
Organised by: Logo
Read full article
ESC Journals

Contributors

Johann Bauersachs
Johann Bauersachs

Author

Hannover Medical School Hannover , Germany

You may be interested in
thumbnail
Congress Presentation
Comparison of sodium-glucose cotransporter-2 (SGLT2) inhibitors to reduce cardiovascular and renal outcomes: a network meta-analysis of randomized controlled trials
28 August 2023
thumbnail
Congress Session
Diabetes, obesity, and heart failure
19 May 2025
thumbnail
Congress Presentation
Lower risk of gout in sodium glucose cotransporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP4) inhibitors in type-2 diabetes patients: a propensity score-matched study
27 August 2022
thumbnail
Congress Presentation
Gliflozines in active cancer patients with heart failure: final results on safety and effectiveness in the observational TOSCA trial
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources